Should GLP-1 agonists should be used earlier in type 2 diabetes?
In the future, GLP-1 agonists could be used early in treatment for type II diabetes and this could have an important impact on slowing the onset of complications,… read more.
In the future, GLP-1 agonists could be used early in treatment for type II diabetes and this could have an important impact on slowing the onset of complications,… read more.
GLP-1 agonists such as semaglutide were developed for treatment of type II diabetes but have also been successful as weight-loss agents for non-diabetics. Many new agents are now… read more.
A study from Queen Mary University of London shows that British people of South Asian heritage are less likely to be able to respond to clopidogrel when prescribed… read more.
Incorrect penicillin allergy labels can result in patients receiving less effective or more toxic antimicrobial agents but a pilot study has shown that a pharmacy-led multidisciplinary team can… read more.
A total of 56 patients were successfully de-labelled in the pilot study but a key challenge will be preventing the erroneous reappearance of the penicillin allergy label, according… read more.
Incorrect penicillin allergy labels can result in patients receiving less effective or more toxic antimicrobial agents but a recent publication has shown that a pharmacy-led multidisciplinary team can… read more.
‘Innovations in Clinical Pharmacy Practice, Education and Research’ will be the topic of the forthcoming ESCP Symposium, to be held in Aberdeen, Scotland in Autumn 2023. In this… read more.
The Oath to Society, jointly developed by ESCP and EAHP underpins clinical pharmacy services and highlights pharmacists’ work to those outside the profession, according to ESCP President, Professor… read more.
ESCP recognises that the translation of academic evidence into day-to-day practice is an important step in the development of clinical pharmacy services – and ESCP Best Practice papers… read more.
ESCP is a dynamic organisation that responds to the needs of its members and in doing so it has undertaken a number of key developments in recent years,… read more.
‘Innovations in Clinical Pharmacy Practice, Education and Research’ will be the topic of the forthcoming ESCP Symposium, to be held in Aberdeen, Scotland in Autumn 2023. IMI spoke… read more.
Ivermectin is an effective antiviral agent with a long record of successful use in human and animal parasite infestations. Its value as part of the early treatment for… read more.
Advertisment